Low Price with Good Quality Acipimox CAS#51037-30-0

• Powder: Yes
• Customized: Non-Customized
• Certification: GMP, HSE, ISO 9001
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Model NO.: Acipimox
• Other Names: Acipimox
• CAS No.: 51037-30-0
• Type: Pharmaceutical Intermediates
• Application: Material Intermediates
• Transport Package: 25kgs Drum
• Specification: 99%purity
• Trademark: lonwin
• Origin: Made in China
• HS Code: 2933290090
• Production Capacity: 20000kgs

Product Description

Quick Details

CAS No.:

51037-30-0

Other Names:

Acipimox

MF:

C6H6N2O3

EINECS No.:

256-928-3

Place of Origin:

China

Type:

Pharmaceutical Intermediates

Purity:

99

Brand Name:

Lonwinchem

Model Number:

TYA-02

Application:

Material Intermediates

Appearance:

white powder

Supply Ability

Supply Ability
1000 Kilogram/Kilograms per Month

Packaging & Delivery

Packaging Details
10g/bag 1kg/bag Two-layer packaging,out layer is PE,inner layer is foil bag,packed with carton
Port
main port in China
Picture Example:

 

 

Lead Time:

Quantity(Grams)	1 - 1000	>1000
Est. Time(days)	7	To be negotiated

 

 

Products Description

 

Product name	Acipimox
CAS	51037-30-0
Appearance	white powder
Assay	99
Storage	Cool and Protect from light

Product Paramenter

Product Name:Acipimox CAS:51037-30-0 MF:C6H6N2O3 MW:154.12 EINECS:256-928-3 Mol File:51037-30-0.mol

Melting point:177-180 °C Boiling point:539.0±45.0 °C(Predicted) Density 1.44±0.1 g/cm3(Predicted) storage temp. 2-8°C pka2.80±0.10(Predicted) Merck 14,111

 

DescriptionAcipimox is a potent long-acting antilipolytic nicotinic acid (NA) analog. Like nicotinic acid, acipimox lowers lipids effectively, but unlike nicotinic acid, acipimox is longer acting and therefore much less prone to produce free fatty acid rebounding. Acipimox is recommended as a lipid-lowering agent to treat hyperlipidemia in patients with noninsulin dependent diabetes mellitus. Acipimox is a hypolipidemic agent related to nicotinic acid with pronounced, longlasting antilipolytic activity. In addition to its lipid lowering activity, it produces a beneficial elevation of the anti-atherogenic high density lipoprotein subfraction, HDL2. UsesAntilipemic.